Disturbances associated with IFG result in an increase in hepatic glucose production and fasting hyperglycemia, but during activity, its plasma concentration gradually decreases as it is used as energy by muscles that remain insulin sensitive. The gene discussed is INS; the disease is Hyperglycemia.